01 May 2020 --- Consumers are increasingly wary of verifying the efficacy of products, meaning scientific backing has never been more critical. However, the rise of COVID-19 could throw a wrench in many companies’ plans for clinical trials as lockdowns and social distancing restrictions continue around the globe. NutritionInsight examines to what extent R&D may be affected and how long these impacts may last, as researchers push for trials to continue.
